洞察市场格局
解锁药品研发情报

免费客服电话

18983288589
试用企业版

【ChiCTR2300072840】EFFICACY OF 308 NM MONOCHROMATIC EXCIMER LAMP AND TOPICAL TACROLIMUS COMBINATION THERAPY IN LOCALISED VITILIGO: A STUDY IN VIETNAM

基本信息
登记号

ChiCTR2300072840

试验状态

结束

药物名称

/

药物类型

/

规范名称

/

首次公示信息日的期

2023-06-26

临床申请受理号

/

靶点

/

适应症

Localised vitiligo

试验通俗题目

EFFICACY OF 308 NM MONOCHROMATIC EXCIMER LAMP AND TOPICAL TACROLIMUS COMBINATION THERAPY IN LOCALISED VITILIGO: A STUDY IN VIETNAM

试验专业题目

EFFICACY OF 308 NM MONOCHROMATIC EXCIMER LAMP AND TOPICAL TACROLIMUS COMBINATION THERAPY IN LOCALISED VITILIGO: A STUDY IN VIETNAM

申办单位信息
申请人联系人
申请人名称
联系人邮箱
联系人邮编

10000

联系人通讯地址
临床试验信息
试验目的

Combination therapy of a 308 nm monochromatic excimer lamp and topical tacrolimus is widely used in the treatment of localised vitiligo; however, there are no published studies investigating this combination therapy in Vietnamese patients with vitiligo. This study was performed to evaluate the efficacy of combined excimer lamp and topical tacrolimus therapy for patients with localised vitiligo in Vietnam.

试验分类
试验类型

单臂

试验分期

其它

随机化

Convenience sampling of the patients who met the inclusion and exclusion criteria.

盲法

N/A

试验项目经费来源

Giving permission to conduct the study. Self-funded.

试验范围

/

目标入组人数

30

实际入组人数

/

第一例入组时间

2019-07-01

试验终止时间

2021-09-30

是否属于一致性

/

入选标准

The inclusion criteria were as follows: 1. Diagnosis of localised vitiligo; 2. Aged >= 2 years; 3. Acquiring the disease for at least 3 months; 4. Either in active or stable stage.;

排除标准

Exclusion criteria included: 1. Pregnancy or breastfeeding; 2. History of skin cancer; 3. Prior treatment with any phototherapy or systemic immunosuppressant drugs; 4. Not undergoing 3-months washout period from topical treatment before starting the combination therapy; 5. Contraindications for phototherapy and topical tacrolimus.;

研究者信息
研究负责人姓名
试验机构

Hanoi Medical University

研究负责人电话
研究负责人邮箱
研究负责人邮编

10000

联系人通讯地址
<END>

最新临床资讯

对摩熵医药数据库感兴趣,可以免费体验产品